Active ingredient
Elranatamab
3 finished FDA listings contain Elranatamab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- ELRANATAMAB
- Dosage forms
- Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 2
- Strengths listed
- 44 mg/1.1ml · 76 mg/1.9ml
- Brand names in FDA listings
- Elrexfio
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2644880
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 761345 | PFIZER INC | 2023-08-14 | 3 |
Official labeling on DailyMed
- ELREXFIO (ELRANATAMAB-BCMM) INJECTION, SOLUTION [U.S. PHARMACEUTICALS] · version 5 · 2026-05-20
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.